Fifth Third Bancorp’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.46K | Sell |
155
-107
| -41% | -$959 | ﹤0.01% | 4129 |
|
|
2026
Q1 | $2.13K | Buy |
+262
| New | +$2.38K | ﹤0.01% | 4021 |
|
|
2023
Q1 | – | Sell |
-1,010
| Closed | -$10.4K | – | 2814 |
|
|
2022
Q4 | $10.4K | Hold |
1,010
| – | – | ﹤0.01% | 1944 |
|
|
2022
Q3 | $18K | Hold |
1,010
| – | – | ﹤0.01% | 1733 |
|
|
2022
Q2 | $52K | Hold |
1,010
| – | – | ﹤0.01% | 1341 |
|
|
2022
Q1 | $74K | Hold |
1,010
| – | – | ﹤0.01% | 1306 |
|
|
2021
Q4 | $145K | Hold |
1,010
| – | – | ﹤0.01% | 1119 |
|
|
2021
Q3 | $209K | Hold |
1,010
| – | – | ﹤0.01% | 965 |
|
|
2021
Q2 | $214K | Sell |
1,010
-25
| -2% | -$4.58K | ﹤0.01% | 961 |
|
|
2021
Q1 | $188K | Sell |
1,035
-390
| -27% | -$77.7K | ﹤0.01% | 963 |
|
|
2020
Q4 | $159K | Sell |
1,425
-165
| -10% | -$17.5K | ﹤0.01% | 1003 |
|
|
2020
Q3 | $172K | Buy |
1,590
+530
| +50% | +$64.6K | ﹤0.01% | 928 |
|
|
2020
Q2 | $88K | Buy |
1,060
+50
| +5% | +$1.91K | ﹤0.01% | 1131 |
|
|
2020
Q1 | $14K | Buy |
+1,010
| New | +$8.55K | ﹤0.01% | 1622 |
|
|
2019
Q4 | – | Sell |
-100
| Closed | -$1K | – | 2297 |
|
|
2019
Q3 | $1K | Buy |
+100
| New | +$547 | ﹤0.01% | 2119 |
|
|
2019
Q1 | – | Sell |
-150
| Closed | -$6K | – | 2255 |
|
|
2018
Q4 | $6K | Buy |
+150
| New | +$5.81K | ﹤0.01% | 1926 |
|
|
2018
Q2 | – | Sell |
-5
| Closed | – | – | 2345 |
|
|
2018
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 2361 |
|
|
2017
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 2329 |
|
|
2017
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 2257 |
|
|
2017
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 2238 |
|
|
2017
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 2190 |
|
|
2016
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 2254 |
|
|
2016
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 2275 |
|
|
2016
Q2 | $1K | Hold |
5
| – | – | ﹤0.01% | 2183 |
|
|
2016
Q1 | $1K | Hold |
5
| – | – | ﹤0.01% | 2246 |
|
|
2015
Q4 | $1K | Hold |
5
| – | – | ﹤0.01% | 2632 |
|
|
2015
Q3 | $1K | Hold |
5
| – | – | ﹤0.01% | 2764 |
|
|
2015
Q2 | $1K | Hold |
5
| – | – | ﹤0.01% | 2744 |
|
|
2015
Q1 | $1K | Hold |
5
| – | – | ﹤0.01% | 2646 |
|
|
2014
Q4 | $1K | Buy |
+5
| New | +$523 | ﹤0.01% | 2302 |
|
|
2014
Q2 | – | Sell |
-19
| Closed | -$2K | – | 2418 |
|
|
2014
Q1 | $2K | Buy |
+19
| New | +$2.12K | ﹤0.01% | 2233 |
|
Other funds holding NVAX
SCM
S
Fifth Third Bancorp's NVAX Position: Q2 2026 in Review
Fifth Third Bancorp reduced its Novavax (NVAX) stake by 41% in Q2 2026, selling an estimated $959 and leaving 155 shares worth $1.46K. The position accounts for ﹤0.01% of the portfolio, ranked #4129.
Fifth Third Bancorp first reported a position in NVAX in Q1 2014 and has held it in 31 quarters since. The position peaked at $214K in Q2 2021. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.
- Fifth Third Bancorp held 155 shares of Novavax worth $1.46K as of Q2 2026.
- Fifth Third Bancorp sold 107 Novavax shares in Q2 2026, an estimated $959.
- Novavax made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #4129 holding.
- Fifth Third Bancorp first reported a position in Novavax in Q1 2014 and has held it in 31 quarters since.
- Fifth Third Bancorp's Novavax position peaked at $214K in Q2 2021.
- 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.
Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.